theory clinical_30_4
imports Main

begin

typedecl entity
typedecl event

consts
  Mutation :: "entity ⇒ bool"
  Activating :: "entity ⇒ bool"
  CTNNB1 :: "entity ⇒ bool"
  Proliferation :: "entity ⇒ bool"
  Cell :: "entity ⇒ bool"
  Promote :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  Patient :: "event ⇒ entity ⇒ bool"
  Via :: "event ⇒ entity ⇒ bool"
  βCatenin :: "entity ⇒ bool"
  Inhibit :: "event ⇒ bool"
  Reduce :: "event ⇒ bool"
  Stop :: "event ⇒ bool"
  Cause :: "event ⇒ entity ⇒ bool"
  Considered :: "event ⇒ bool"
  Effective :: "event ⇒ bool"
  Treatment :: "event ⇒ bool"
  For :: "event ⇒ entity ⇒ bool"
  Through :: "event ⇒ event ⇒ bool"
  Treat :: "event ⇒ bool"

(* Explanation 1: Activating mutations of CTNNB1 promote proliferation of cells via β-catenin. *)
axiomatization where
  explanation_1: "∃x y z e. Mutation x ∧ Activating x ∧ CTNNB1 x ∧ Proliferation y ∧ Cell z ∧ Promote e ∧ Agent e x ∧ Patient e y ∧ Via e z ∧ βCatenin z"

(* Explanation 2: Inhibiting β-catenin can reduce or stop the proliferation of cells caused by activating mutations of CTNNB1. *)
axiomatization where
  explanation_2: "∃x y z e1 e2. Inhibit e1 ∧ βCatenin x ∧ Proliferation y ∧ Cell z ∧ Mutation z ∧ Activating z ∧ CTNNB1 z ∧ (Reduce e2 ∨ Stop e2) ∧ Agent e1 x ∧ Patient e2 y ∧ Cause e2 z"

(* Explanation 3: Reducing or stopping the proliferation of cells through inhibiting β-catenin is considered an effective treatment for patients with activating CTNNB1 mutations. *)
axiomatization where
  explanation_3: "∃x y z e1 e2 e3. Proliferation x ∧ Cell y ∧ Inhibit e1 ∧ βCatenin z ∧ Mutation z ∧ Activating z ∧ CTNNB1 z ∧ (Reduce e2 ∨ Stop e2) ∧ Agent e1 z ∧ Patient e2 x ∧ Through e2 e1 ∧ Considered e3 ∧ Effective e3 ∧ Treatment e3 ∧ For e3 z"

theorem hypothesis:
  assumes asm: "βCatenin x ∧ Mutation y ∧ Activating y ∧ CTNNB1 y"
  (* Hypothesis: Inhibiting β-catenin may be effective in treating patients with activating CTTNB1 mutations. *)
  shows "∃x y e1 e2. Inhibit e1 ∧ βCatenin x ∧ Mutation y ∧ Activating y ∧ CTNNB1 y ∧ Agent e1 x ∧ Effective e2 ∧ Treat e2 ∧ Agent e2 x ∧ Patient e2 y"
proof -
  (* From the premise, we have known information about β-catenin and activating mutations of CTNNB1. *)
  from asm have "βCatenin x ∧ Mutation y ∧ Activating y ∧ CTNNB1 y" by simp
  (* Explanation 2 provides a logical relation: Implies(D, E), Implies(inhibiting β-catenin, effective treatment for patients with activating CTNNB1 mutations) *)
  (* We need to show that inhibiting β-catenin is effective in treating patients with activating CTNNB1 mutations. *)
  (* Explanation 3 supports this by stating that reducing or stopping the proliferation of cells through inhibiting β-catenin is considered an effective treatment. *)
  from explanation_3 have "∃e1 e2. Inhibit e1 ∧ βCatenin x ∧ Mutation y ∧ Activating y ∧ CTNNB1 y ∧ Agent e1 x ∧ Effective e2 ∧ Treatment e2 ∧ For e2 y" sledgehammer
  (* Therefore, we can conclude that inhibiting β-catenin may be effective in treating patients with activating CTNNB1 mutations. *)
  then show ?thesis <ATP>
qed

end
